Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00672048
Other study ID # Pro00002593
Secondary ID R01EY018405-01
Status Completed
Phase N/A
First received May 4, 2008
Last updated January 3, 2014
Start date October 2007
Est. completion date July 2013

Study information

Verified date December 2013
Source Duke University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to develop new ways of assisting patients with glaucoma and their eye doctors in using the recommendations from practice guidelines.


Description:

Glaucoma is a leading cause of blindness and visual impairment in the United States, particularly among disadvantaged populations. Despite the presence of therapies proven in NEI, randomized controlled trials that can be delivered by more than 18,000 ophthalmologists and 34,000 optometrists, almost nothing is known about the content and quality of glaucoma care delivered by non-MD providers such as optometrists. With the numbers of people with glaucoma expected to more than double in the next twenty years in the face of no more than a 15% increase in the supply of eye care providers, methods to better support appropriate and high-quality care for chronic eye diseases such as glaucoma delivered by optometrists will become as critical, if not more so, as techniques to enhance quality care among ophthalmologists.

Our study is a community-based, randomized, controlled trial that evaluates the suitability and effectiveness of a technology-based (tablet computer) intervention within the context of a novel partnership between optometrists and patients with glaucoma to improve the process quality of care and ultimately outcomes of care. By using successfully implemented technology in novel applications,and by building on the success of ongoing community-based quality improvement projects in our region, the study provides a means for rapid translation into community care if the intervention is successful.


Other known NCT identifiers
  • NCT01733498

Recruitment information / eligibility

Status Completed
Enrollment 721
Est. completion date July 2013
Est. primary completion date July 2013
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

-Diagnosis of open angle glaucoma with documented visual field loss.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Computer Tablet
A tablet computer based software application designed to collect structured clinical information from providers and patients at the point of care.
Continuing Education Course
Annual standard continuing education
Continuing education
Annual standard continuing education materials

Locations

Country Name City State
United States University of Alabama Birmingham Alabama
United States Duke University Durham North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Duke University University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

References & Publications (4)

Kacmaz RO, Arbanas JM, Lee PP, Lobach DF. Assessment of relative importance of tablet computer features in supporting direct electronic documentation of encounters by eye care professionals. AMIA Annu Symp Proc. 2005:1001. — View Citation

Lobach DF, Silvey GM, Macri JM, Hunt M, Kacmaz RO, Lee PP. Identifying and overcoming obstacles to point-of-care data collection for eye care professionals. AMIA Annu Symp Proc. 2005:465-9. — View Citation

Silvey GM, Lobach DF, Macri JM, Hunt M, Kacmaz RO, Lee PP. Overcoming obstacles to collecting narrative data from eye care professionals at the point-of-care. AMIA Annu Symp Proc. 2005:1116. — View Citation

Silvey GM, Lobach DF, Macri JM, Hunt M, Kacmaz RO, Lee PP. User interface considerations for collecting data at the point of care in the tablet PC computing environment. AMIA Annu Symp Proc. 2006:1096. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary To determine if innovative technology will improve process quality of care & important outcomes of care by optometrists in a cost-efficient manner while simultaneously empowering & including patients as part of the care process. Baseline, Year 1 and Year 2 No
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT06278597 - Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03274024 - The Asia Primary Tube Versus Trab (TVT) Study N/A
Completed NCT04552964 - Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma N/A
Recruiting NCT01957267 - Functional and Structural Imaging for Glaucoma
Active, not recruiting NCT04624698 - iStent Inject New Enrollment Post-Approval Study N/A
Completed NCT04020705 - The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma N/A
Completed NCT03150160 - Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Phase 4
Not yet recruiting NCT05581498 - Glaucoma Exercise as Medicine Study (GEMS). N/A
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Active, not recruiting NCT02901730 - Clinical Study of LPI With Different Laser Wavelengths N/A
Completed NCT02955849 - A Trial of China Laser and Surgery Study Glaucoma in Rural China Early Phase 1
Recruiting NCT02554214 - Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device N/A
Recruiting NCT02471105 - Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Phase 4
Active, not recruiting NCT02390284 - Stop Retinal Ganglion Cell Dysfunction Study Phase 3
Completed NCT02628223 - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma N/A
Completed NCT02653963 - Triamcinolone for Ahmed Glaucoma Valve N/A
Completed NCT02520674 - Glaucoma Screening With Smartphone Ophthalmology N/A
Completed NCT02246764 - Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Phase 3